Carregant...
Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells
Targeted cancer therapy includes, amongst others, antibody-based delivery of toxic payloads to selectively eliminate tumor cells. This payload can be either a synthetic small molecule drug composing an antibody-drug conjugate (ADC) or a cytotoxic protein composing an immunotoxin (IT). Non-human cyto...
Guardat en:
| Publicat a: | Biomedicines |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5874685/ https://ncbi.nlm.nih.gov/pubmed/29510557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines6010028 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|